E-cigarettes: The science behind the smoke and mirrors

Respiratory Care

Volumn 61, Issue 8, 2016, Pages 1122-1128

  Cobb, Nathan K ^a   Sonti, Rajiv ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cigarettes; e cigarettes; Harm reduction; Nicotine replacement; Regulation; Safety; Smoking cessation

Indexed keywords

CIGARETTE SMOKE; FLAVORING AGENT; FORMALDEHYDE; GLYCEROL; INTERLEUKIN 6; NICOTINE; PROPYLENE GLYCOL; NICOTINE GUM;

ARTICLE; ASPIRATION PNEUMONIA; ELECTRONIC CIGARETTE; FOOD AND DRUG ADMINISTRATION; HEALTH PRACTITIONER; HEART RATE; HUMAN; LUNG RESISTANCE; MARKET; META ANALYSIS (TOPIC); NICOTINE REPLACEMENT THERAPY; PARTICULATE MATTER; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY SYSTEM; SMOKING CESSATION; VAPOR; PROCEDURES; SMOKING; THERAPY; UNITED STATES;

ELECTRONIC CIGARETTES; HUMANS; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; UNITED STATES;

EID: 84982295105     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.04944     Document Type: Article

References (60)

1. Zhu SH, Sun JY, Bonnevie E, Cummins SE, Gamst A, Yin L, Lee M. Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob Control 2014;23(Suppl 3):iii3-iii9.
2. Grana R, Benowitz N, Glantz SA. E-cigarettes: a scientific review. Circulation 2014;129(19):1972-1986.
3. Schoenborn CA, Gindi RM. Electronic cigarette use among adults: United States, 2014. NCHS Data Brief 2015(217).
4. Arrazola RA, Singh T, Corey CG, Husten CG, Neff LJ, Apelberg BJ, et al. Tobacco use among middle and high school students: United States, 2011-2014. MMWR Morb Mortal Wkly Rep 2015;64(14): 381-385.
5. McNeill A, Brose LS, Calder R, Hitchman SC, Hajek P, McRobbie H. E-cigarettes: an evidence update. London, United Kingdom: Public Health England; 2015.
6. American Lung Association statement on e-cigarettes. http:// www.lung.org/our-initiatives/tobacco/oversight-and-regulation/ statement-on-e-cigarettes.html. Accessed March 23, 2016.
7. Brandon TH, Goniewicz ML, Hanna NH, Hatsukami DK, Herbst RS, Hobin JA, et al. Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology. Clin Cancer Res 2015; 21(3):514-25.
8. Rojewski AM, Coleman NC, Toll BA. Emerging policy issues regarding electronic nicotine delivery systems: a need for regulation. http://www.sbm.org/UserFiles/file/e-cig-statement_v2_lores.pdf. Accessed 23 Mar 2016.
9. Pearson JL, Stanton CA, Cha S, Niaura RS, Luta G, Graham AL. E-cigarettes and smoking cessation: insights and cautions from a secondary analysis of data from a study of online treatment-seeking smokers. Nicotine Tob Res 2015;17(10):1219-1227.
10. Siu AL, U.S. Preventive Services Task Force. Behavioral and phar-macotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2015;163(8):622-634.
11. Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2012;(11):CD000146.
12. Kalkhoran S, Glantz SA. Modeling the health effects of expanding e-cigarette sales in the United States and United Kingdom: A Monte Carlo analysis. JAMA Intern Med 2015;175(10):1671-1680.
13. Walton KM, Abrams DB, Bailey WC, Clark D, Connolly GN, Djord-jevic MV, et al. NIH electronic cigarette workshop: developing a research agenda. Nicotine Tob Res 2015;17(2):259-269.
14. Brown CJ, Cheng JM. Electronic cigarettes: product characterisation and design considerations. Tob Control 2014;23(Suppl 2):ii4-ii10.
15. Wieslander G, Norbäck D, Lindgren T. Experimental exposure to propylene glycol mist in aviation emergency training: acute ocular and respiratory effects. Occup Environ Med 2001;58(10):649-655.
16. Flora JW, Meruva N, Huang CB, Wilkinson CT, Ballentine R, Smith DC, et al. Characterization of potential impurities and degradation products in electronic cigarette formulations and aerosols. Regul Toxicol Pharmacol 2016;74:1-11.
17. US Food and Drug Administration. Evaluation of e-cigarettes. May 4, 2009. http://www.fda.gov/downloads/Drugs/ScienceResearch/ UCM173250.pdf. Accessed Mar 6, 2010.
18. Cobb NK, Byron MJ, Abrams DB, Shields PG. Novel nicotine delivery systems and public health: the rise of the “e-cigarette”. Am J Public Health 2010;100(12):2340-2342.
19. Schier JG, Rubin CS, Miller D, Barr D, McGeehin MA. Medication-associated diethylene glycol mass poisoning: a review and discussion on the origin of contamination. J Public Health Policy 2009; 30(2):127-143.
20. Han S, Chen H, Zhang X, Liu T, Fu Y. Levels of selected groups of compounds in refill solutions for electronic cigarettes. Nicotine Tob Res 2016;18(5):708-714.
21. Goniewicz ML, Gupta R, Lee YH, Reinhardt S, Kim S, Kim B, et al. Nicotine levels in electronic cigarette refill solutions: a comparative analysis of products from the US, Korea, and Poland. Int J Drug Policy 2015;26(6):583-588.
22. Bassett RA, Osterhoudt K, Brabazon T. Nicotine poisoning in an infant. N Engl J Med 2014;370(23):2249-2250.
23. Chatham-Stephens K, Law R, Taylor E, Melstrom P, Bunnell R, Wang B, et al. Notes from the field: calls to poison centers for exposures to electronic cigarettes: United States, Sept 2010-Feb 2014. MMWR Morbid Mortal Wkly Rep 2014;63(13):292-293.
24. Gillman IG, Kistler KA, Stewart EW, Paolantonio AR. Effect of variable power levels on the yield of total aerosol mass and formation of aldehydes in e-cigarette aerosols. Regul Toxicol Pharmacol 2016;75:58-65.
25. Uchiyama S, Ohta K, Inaba Y, Kunugita N. Determination of car-bonyl compounds generated from the e-cigarette using coupled silica cartridges impregnated with hydroquinone and 2,4-dinitrophenylhy-drazine, followed by high-performance liquid chromatography. Anal Sci 2013;29(12):1219-1222.
26. Herrington JS, Myers C. Electronic cigarette solutions and resultant aerosol profiles. J Chromatogr A 2015;1418:192-199.
27. Ingebrethsen BJ, Cole SK, Alderman SL. Electronic cigarette aerosol particle size distribution measurements. Inhal Toxicol 2012;24(14): 976-984.
28. Zhang Y, Sumner W, Chen DR. In vitro particle size distributions in electronic and conventional cigarette aerosols suggest comparable deposition patterns. Nicotine Tob Res 2013;15(2):501-508.
29. Hwang JH, Lyes M, Sladewski K, Enany S, McEachern E, Mathew DP, et al. Electronic cigarette inhalation alters innate immunity and airway cytokines while increasing the virulence of colonizing bacteria. J Mol Med (Berl) 2016 [Epub ahead of print] doi: 10.1007/ s00109-016-1378-3.
30. Farsalinos KE, Romagna G, Allifranchini E, Ripamonti E, Bocchi-etto E, Todeschi S, et al. Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells. Int J Environ Res Public Health 2013;10(10):5146-5162.
31. Bahl V, Lin S, Xu N, Davis B, Wang YH, Talbot P. Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod Toxicol 2012;34(4):529-537.
32. Wu Q, Jiang D, Minor M, Chu HW. Electronic cigarette liquid increases inflammation and virus infection in primary human airway epithelial cells. PLoS One 2014;9(9):e108342.
33. Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest 2012;141(6):1400-1406.
34. Flouris AD, Chorti MS, Poulianiti KP, Jamurtas AZ, Kostikas K, Tzatzarakis MN, et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol 2013;25(2):91-101.
35. Czogala J, Goniewicz ML, Fidelus B, Zielinska-Danch W, Travers MJ, Sobczak A. Secondhand exposure to vapors from electronic cigarettes. Nicotine Tob Res 2014;16(6):655-662.
36. Benowitz NL. Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Prog Cardiovasc Dis 2003; 46(1):91-111.
37. St Helen G, Havel C, Dempsey DA, Jacob P 3rd, Benowitz NL. Nicotine delivery, retention, and pharmacokinetics from various electronic cigarettes. Addiction 2016;111(3):535-544.
38. Vansickel AR, Cobb CO, Weaver MF, Eissenberg TE. A clinical laboratory model for evaluating the acute effects of electronic “cig-arettes”: nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev 2010;19(8):1945-1953.
39. Lopez AA, Hiler MM, Soule EK, Ramôa CP, Karaoghlanian NV, Lipato T, et al. Effects of electronic cigarette liquid nicotine concentration on plasma nicotine and puff topography in tobacco cigarette smokers: a preliminary report. Nicotine Tob Res 2016;18(5): 720-723.
40. Evans SE, Hoffman AC. Electronic cigarettes: abuse liability, topography and subjective effects. Tob Control 2014;23(Suppl 2):ii23-ii29.
41. Vansickel AR, Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res 2013;15(1): 267-270.
42. Vansickel AR, Weaver MF, Eissenberg T. Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction 2012;107(8):1493-1500.
43. Farsalinos KE, Spyrou A, Tsimopoulou K, Stefopoulos C, Romagna G, Voudris V. Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci Rep 2014; 4:4133.
44. Delnevo CD, Giovenco DP, Steinberg MB, Villanti AC, Pearson JL, Niaura RS, Abrams DB. Patterns of electronic cigarette use among adults in the United States. Nicotine Tob Res 2016;18(5):715-719.
45. Warner KE. Frequency of e-cigarette use and cigarette smoking by American students in 2014. Am J Prev Med 2016 [Epub ahead of print] doi: 10.1016/j.amepre.2015.12.004.
46. Primack BA, Soneji S, Stoolmiller M, Fine MJ, Sargent JD. Progression to traditional cigarette smoking after electronic cigarette use among US adolescents and young adults. JAMA Pediatr 2015; 169(11):1018-1023.
47. Rahman MA, Hann N, Wilson A, Mnatzaganian G, Worrall-Carter L. E-cigarettes and smoking cessation: evidence from a systematic review and meta-analysis. PLoS One 2015;10(3)
48. McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P. Electronic cigarettes for smoking cessation and reduction. Cochrane Database Syst Rev 2014;(12):CD010216.
49. Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med 2016;4(2):116-128.
50. Tseng TY, Ostroff JS, Campo A, Gerard M, Kirchner T, Rotrosen J, Shelley D. A randomized trial comparing the effect of nicotine versus placebo electronic cigarettes on smoking reduction among young adult smokers. Nicotine Tob Res 2016 [Epub ahead of print] doi: 10.1093/ntr/ntw017.
51. Nutt DJ, Phillips LD, Balfour D, Curran HV, Dockrell M, Foulds J, et al. Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res 2014;20(5):218-225.
52. Lynch R. Are smokeless cigarettes safer? E-cig explodes in smoker’s mouth. Los Angeles Times. February 16, 2012. http://latimesblogs-.latimes.com/nationnow/2012/02/electronic-cigarette-explodes-mans-mouth.html Accessed March 4, 2012.
53. Colaianni CA, Tapias LF, Cauley R, Sheridan R, Schulz JT, Goverman J. Injuries caused by explosion of electronic cigarette devices. Eplasty 2016;16:ic9.
54. Williams M, Villarreal A, Bozhilov K, Lin S, Talbot P. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One 2013;8(3): e57987.
55. Jensen RP, Luo W, Pankow JF, Strongin RM, Peyton DH. Hidden formaldehyde in e-cigarette aerosols. N Engl J Med 2015;372(4):392-394.
56. McCauley L, Markin C, Hosmer D. An unexpected consequence of electronic cigarette use. Chest 2012;141(4):1110-1113.
57. Cobb NK, Abrams DB. The FDA, e-cigarettes, and the demise of combusted tobacco. N Engl J Med 2014;371(16):1469-1471.
58. Deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act, as amended by the family smoking prevention and tobacco control act: regulations on the sale and distribution of tobacco products and required warning statements for tobacco products. Federal Register 2014;79:23141-23207.
59. West R, Shahab L, Brown J. Estimating the population impact of e-cigarettes on smoking cessation in England. Addiction 2016;111(6): 1118-1119.
60. Koh HK, Sebelius KG. Promoting prevention through the Affordable Care Act. N Engl J Med 2010;363(14):1296-1299.